Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Greaves

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 9, 2005
Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancerAndrew R Green, Jerry A Styles, Emma L Parrott, et al.
Cancer Research|August 3, 2002
Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female ratSarah Donald, Richard D Verschoyle, Richard Edwards, et al.
The American Journal of Pathology|March 29, 2005
Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory poolReginald Davies, Arenda Schuurman, Colin R Barker, et al.
Cancer Research|October 3, 2003
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the ratSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Plos One|February 7, 2015
Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary noteMark I James, Lynne M Howells, Ankur Karmokar, et al.
Journal of Toxicologic Pathology|March 15, 2016
Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and MouseThomas Nolte, Patricia Brander-Weber, Charles Dangler, et al.
The Prostate|May 7, 2008
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolismFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
British Journal of Cancer|May 25, 2019
ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteinsQais Al-Ismaeel, Christopher P Neal, Hanaa Al-Mahmoodi, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 9, 2005
Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancerAndrew R Green, Jerry A Styles, Emma L Parrott, et al.
Cancer Research|August 3, 2002
Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female ratSarah Donald, Richard D Verschoyle, Richard Edwards, et al.
The American Journal of Pathology|March 29, 2005
Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory poolReginald Davies, Arenda Schuurman, Colin R Barker, et al.
Cancer Research|October 3, 2003
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the ratSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Plos One|February 7, 2015
Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary noteMark I James, Lynne M Howells, Ankur Karmokar, et al.
Journal of Toxicologic Pathology|March 15, 2016
Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and MouseThomas Nolte, Patricia Brander-Weber, Charles Dangler, et al.
The Prostate|May 7, 2008
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolismFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
British Journal of Cancer|May 25, 2019
ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteinsQais Al-Ismaeel, Christopher P Neal, Hanaa Al-Mahmoodi, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Pageof 5